Esculin
Especificaciones
531-75-9Número CAS
208-517-5Número CE
7-hydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-oneNombre IUPAC
C15H16O9Fórmula química
340.28 g/molPeso molecular
Esculin; 531-75-9; Esculetin 6-O-glucoside; 6,7-Dihydroxycoumarin 6-glucoside; Esculetin 6-beta-D-glucoside; 6,7-Dihydroxycoumarin-6-O-glucoside; 7-Hydroxy-6-cumarinyl-glucosid; DTXSID7045318; 6-(beta-D-Glucopyranosyloxy)-7-hydroxy-cumarin; 1Y1L18LQAF; CHEBI:4853; NSC-26665; DTXCID5025318; 7-hydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one; 7-hydroxy-2-oxo-2H-chromen-6-yl beta-D-glucopyranoside; 2H-1-Benzopyran-2-one, 6-(beta-D-glucopyranosyloxy)-7-hydroxy-; 7-hydroxy-6-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl)oxychromen-2-one; RefChem:35731; 208-517-5; 686-183-3; aesculin; Bicolorin; Enallachrome; Crataegin; Escosyl; Esculine; Vitamin C2; (-)-Esculin; 6-(beta-D-Glucopyranosyloxy)-7-hydroxy-2H-1-benzopyran-2-one; 7-hydroxy-6-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-2H-chromen-2-one; Esculetin 6-b-D-glucoside; Aesculinum; 7-Hydroxy-6-glucosyloxy-2H-chromene; 7-hydroxy-6-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2H-chromen-2-one; 2H-1-Benzopyran-2-one, 6-(.beta.-D-glucopyranosyloxy)-7-hydroxy-; 6-(.beta.-D-Glucopyranosyloxy)-7-hydroxy-2H-1-benzopyran-2-one; 7-hydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-2-one; ESCULOSIDE [JAN]; Venoplant; C15H16O9; MFCD00006879; Aesculetin glukosid; 6-[(2S,3R,4S,5S,6R)-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-7-oxidanyl-chromen-2-one; UNII-1Y1L18LQAF; Esculina; CCRIS 5724; SR-01000633930; esculetin glukosid; Esculin CRS; NCGC00016491-01; CAS-531-75-9; Aesculin (Esculin); EINECS 208-517-5; Esculin (Standard); 7-Hydroxy-6-glucosyloxy-2H-chromen; Esculin - Anhydrous; NSC 26665; Spectrum_000361; ESCULIN [MI]; Spectrum2_000576; Spectrum3_000731; Spectrum4_001923; Spectrum5_000845; AESCULINUM [HPUS]; SCHEMBL2893; ESCULOSIDE [WHO-DD]; BSPBio_002282; KBioGR_002266; KBioSS_000841; DivK1c_000956; SPECTRUM1500901; SPBio_000392; CHEMBL482581; orb1944124; SCHEMBL29350403; BCBcMAP01_000202; Esculetin 6-.beta.-D-glucoside; Esculetin-6-?-D-glucopyranoside; HMS502P18; HY-N0188R; KBio1_000956; KBio2_000841; KBio2_003409; KBio2_005977; KBio3_001502; NINDS_000956; HMS1921M16; EX-A6781; HY-N0188; Tox21_110453; BDBM50480261; CCG-38501; EBC-12127; MSK158084; MSK158084-100AW; s2258; AKOS015895151; DB13155; SDCCGMLS-0066653.P001; IDI1_000956; SMP1_000008; NCGC00094874-04; 7-hydroxy-6-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy- 6-(hydroxymethyl)-2-tetrahydropyranyl]oxy}-2-chromenone; ME163640; CS-0007892; E7310; NS00009922; 7-Hydroxycoumarin-6-yl beta-D-Glucopyranoside; C09264; EN300-116211; T80631; 6-(.beta.-D-Glucopyranosyloxy)-7-hydroxy-cumarin; Esculin Solution in Acetonitrile/Water, 100ug/mL; Q376432; SR-01000633930-1; SR-01000633930-3; BRD-K51742987-001-02-3; BRD-K51742987-002-02-1; Esculin, European Pharmacopoeia (EP) Reference Standard; Z1494829512; 6-(|_-D-Glucopyranosyloxy)-7-hydroxy-2H-1-benzopyran-2-one; 7-Hydroxy-2-oxo-2H-1-benzopyran-6-yl beta-D-glucopyranoside; 7OUSinónimos
